FDA Inspection 634729 — Lange, Gudrun Ph.D.,

Lange, Gudrun Ph.D., — FEI 3007058922

The FDA completed an inspection of Lange, Gudrun Ph.D., on Dec 3, 2009 in Newark, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 3, 2009
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Newark, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
1450521 CFR 812.140(a)(3)Investigator's subject records inadequate
1450721 CFR 812.140(a)(3)(ii)Investigator adverse effect records inadequate
292821 CFR 812.40Sponsors' general responsibilities
298121 CFR 812.140(a)(2)(i)Investigator device accountability inadequate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.